Iterum Therapeutics Plc(ITRM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ITRM Iterum Therapeutics Plc

Pre-Market Trading 07-01 06:02:09 EDT

1.15

-0.05

-4.58%

High1.26	Low1.08	Vol269.70K
Open1.23	D1 Closing1.20	Amplitude15.00%
Mkt Cap18.96M	Tradable Cap18.59M	Total Shares16.55M
T/O313.96K	T/O Rate1.66%	Tradable Shares16.23M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ITRM","market":"US","secType":"STK","nameCN":"Iterum Therapeutics Plc","latestPrice":1.145,"timestamp":1719604800000,"preClose":1.2,"halted":0,"volume":269697,"delay":0,"floatShares":16234966,"shares":16554885,"eps":-2.606801,"marketStatus":"Pre-Market Trading","change":-0.055,"latestTime":"07-01 06:02:09 EDT","open":1.23,"high":1.26,"low":1.08,"amount":313957.0825488,"amplitude":0.15,"askPrice":1.3,"askSize":26,"bidPrice":0.8963,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.606801,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1719840600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1527220800000,"exchange":"NASDAQ","adjPreClose":1.16,"postHourTrading":{"tag":"盘后","latestPrice":1.1701,"preClose":1.145,"latestTime":"19:39 EDT","volume":269,"amount":315.6667,"timestamp":1719617967924},"volumeRatio":2.039032270158309},"requestUrl":"/m/hq/s/ITRM","defaultTab":"news","newsList":[{"id":"2445779143","title":"Sector Update: Health Care Stocks Gain in Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2445779143","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445779143?lang=en_us&edition=fundamental","pubTime":"2024-06-22 03:53","pubTimestamp":1718999585,"startTime":"0","endTime":"0","summary":"Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund  adding 0.3%.The iShares Biotechnology ETF  rose 1.1%.In corporate news, Iterum Therapeutics  shares jumped 6.5% after the US Food and Drug Administration referred its new drug application for oral sulopenem to an advisory committee.Lexicon Pharmaceuticals  gained 6.6% after the company resubmitted its new drug application for sotagliflozin to supplement insulin therapy for people with type 1 diabetes and chronic kidney disease, following multiple consultations with the FDA.Sharecare  surged 76% after the company agreed to be acquired by an Altaris affiliate.Sarepta Therapeutics  received a label expansion from the FDA for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a \"best-case scenario\" and exceeding expectations, BofA Securities said in a report. BofA boosted Sarepta's price target to $213 from $166 and kept the buy rating. Analyst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","SHCR","SRPT","IE00BFTCPJ56.SGD","BK4585","IE00B2B36J28.USD","BK4581","BK4588","IE00BJJMRZ35.SGD","IE0009355771.USD","XLV","BK4139","BK4007","IE00BJT1NW94.SGD","ITRM","LXRX","IBB","BK4167"],"gpt_icon":0},{"id":"2445318793","title":"Iterum Therapeutics Price Target Maintained With a $6.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445318793","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445318793?lang=en_us&edition=fundamental","pubTime":"2024-06-22 01:50","pubTimestamp":1718992200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ITRM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 21, 2024 13:50 ET (17:50 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ITRM"],"gpt_icon":0},{"id":"2445448767","title":"Iterum to face AdCom as FDA reviews lead asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2445448767","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445448767?lang=en_us&edition=fundamental","pubTime":"2024-06-22 00:37","pubTimestamp":1718987860,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics (NASDAQ:ITRM) announced Friday that the U.S. Food and Drug Administration (FDA) has convened an advisory committee meeting as part of an ongoing review of the company’s new drug ap","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4117991-iterum-stock-gains-fda-adcom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4007","ITRM"],"gpt_icon":0},{"id":"2445273751","title":"BRIEF-Iterum Therapeutics Announces FDA Advisory Committee Meeting To Discuss NDA For Oral Sulopenem For Treating Uncomplicated Urinary Tract Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2445273751","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445273751?lang=en_us&edition=fundamental","pubTime":"2024-06-21 20:38","pubTimestamp":1718973528,"startTime":"0","endTime":"0","summary":"June 21  - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO DISCUSS NDA FOR ORAL SULOPENEM FOR THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS   * ITERUM THERAPEUTICS PLC - FDA HAS ASSIGNED A PDUFA ACTION DATE OF OCTOBER 25, 2024.   * ITERUM THERAPEUTICS PLC - PROPOSED DATE FOR FDA ADVISORY COMMITTEE MEETING IS SEPTEMBER 9, 2024.Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4007","ITRM"],"gpt_icon":0},{"id":"2435107055","title":"Analysts Are Bullish on These Healthcare Stocks: IO Biotech (IOBT), Iterum Therapeutics (ITRM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435107055","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435107055?lang=en_us&edition=fundamental","pubTime":"2024-05-14 23:30","pubTimestamp":1715700614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IO Biotech (IOBT – Research Report) and Iterum Thera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-io-biotech-iobt-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-io-biotech-iobt-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IO","BK4139","BK4137","IOBT","ITRM","BK4007","BK4563","BK4179"],"gpt_icon":0},{"id":"2435321475","title":"Q1 2024 Iterum Therapeutics PLC Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2435321475","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435321475?lang=en_us&edition=fundamental","pubTime":"2024-05-14 10:49","pubTimestamp":1715654970,"startTime":"0","endTime":"0","summary":"Louise Barrett; Senior Vice President, Legal Affairs; Iterum Therapeutics PLC. Corey Fishman; Chief Executive Officer, Director; Iterum Therapeutics PLC. Judith Matthews; Chief Financial Officer; Iterum Therapeutics PLC. Hello, and welcome to the Iterum Therapeutics first quarter 2024 financial results and business update. My name is Carla, and I'll be the operator in the call today.  I will now hand you over to your host, Louise Barrett, Senior Vice President of Legal Affairs to begin. Louise, please go ahead.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q1-2024-iterum-therapeutics-plc-024930220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITRM","LENZ"],"gpt_icon":0},{"id":"2435684325","title":"Iterum Therapeutics' Cash, Cash Equivalents And Short-term Investments Were $18.2 Million At March 31, 2024 Will Be Sufficient To Fund Its Operations Into 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2435684325","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435684325?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:03","pubTimestamp":1715598223,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics' Cash, Cash Equivalents And Short-term Investments Were $18.2 Million At March 31, 2024 Will Be Sufficient To Fund Its Operations Into 2025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/05/38784549/iterum-therapeutics-cash-cash-equivalents-and-short-term-investments-were-18-2-million-at-march-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITRM","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2435232568","title":"Iterum Therapeutics Q1 2024 Adj EPS $(0.58) Beats $(0.72) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435232568","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435232568?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:02","pubTimestamp":1715598161,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics Q1 2024 Adj EPS $(0.58) Beats $(0.72) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38784533/iterum-therapeutics-q1-2024-adj-eps-0-58-beats-0-72-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ITRM"],"gpt_icon":0},{"id":"2434891431","title":"Iterum Therapeutics Announces CMO Transition and Consultant Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2434891431","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434891431?lang=en_us&edition=fundamental","pubTime":"2024-05-11 04:35","pubTimestamp":1715373306,"startTime":"0","endTime":"0","summary":"An update from Iterum Therapeutics Plc (ITRM) is now available. Sailaja Puttagunta M.D. will step down as Chief Medical Officer of Iterum Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iterum-therapeutics-announces-cmo-transition-and-consultant-role?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iterum-therapeutics-announces-cmo-transition-and-consultant-role?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","ITRM","CMO","BK4139"],"gpt_icon":0},{"id":"2431529028","title":"Iterum Therapeutics resubmits new drug application to U.S. FDA for oral sulopenem","url":"https://stock-news.laohu8.com/highlight/detail?id=2431529028","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2431529028?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:47","pubTimestamp":1714394821,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics plc (NASDAQ:ITRM) announced that it has resubmitted its New Drug Application to the U.S. FDA for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095445-iterum-therapeutics-resubmits-new-drug-application-to-us-fda-for-oral-sulopenem","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LENZ","BK4007","BK4139","ITRM"],"gpt_icon":0},{"id":"2431568128","title":"BRIEF-Iterum Therapeutics Resubmits New Drug Application To U.S. FDA For Oral Sulopenem","url":"https://stock-news.laohu8.com/highlight/detail?id=2431568128","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2431568128?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:08","pubTimestamp":1714392489,"startTime":"0","endTime":"0","summary":"April 29  - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR ORAL SULOPENEM   * ITERUM THERAPEUTICS PLC: POTENTIAL APPROVAL EARLY Q4 2024Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LENZ","ITRM"],"gpt_icon":0},{"id":"2425510517","title":"BRIEF-Iterum Therapeutics On April 3, Received Letter From Nasdaq Indicating That It Is Not In Compliance With Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2425510517","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2425510517?lang=en_us&edition=fundamental","pubTime":"2024-04-06 05:50","pubTimestamp":1712353820,"startTime":"0","endTime":"0","summary":"April 5 (Reuters) - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS: ON APRIL 3, RECEIVED LETTER FROM NASDAQ INDICATING THAT IT IS NOT IN COMPLIANCE WITH NASDAQ LISTING RULESource text for Eikon: [ID: Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","QLD","QQQ","BK4585","ITRM","PSQ","TQQQ","NQmain","QID","NDAQ","LU2095319765.USD","LU2210150020.SGD","LU2210149790.SGD","BK4112","BK4588","BK4007","SQQQ",".IXIC","MNQmain"],"gpt_icon":0},{"id":"2424042654","title":"Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2424042654","media":"Insider Monkey","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2424042654?lang=en_us&edition=fundamental","pubTime":"2024-04-02 22:22","pubTimestamp":1712067738,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter .Operator: Hello, everyone, and welcome to the Iterum Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Business Update. My name is Emily, and I'll be coordinating your call today. [Operator Instructions] I will now turn the call over to our host, Louise Barrett, Senior Vice President of Legal Affairs. Louise, please go ahead.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/82JeK5c2SI1EuJjtwPG9nA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1a7b98df5e5106a518677a3ffd567808","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/82JeK5c2SI1EuJjtwPG9nA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1a7b98df5e5106a518677a3ffd567808"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iterum-therapeutics-plc-nasdaq-itrm-142218917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ",".IXIC","ITRM"],"gpt_icon":0},{"id":"2424233799","title":"Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2424233799","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2424233799?lang=en_us&edition=fundamental","pubTime":"2024-04-01 18:30","pubTimestamp":1711967416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC – Research Report), Apollomics (AP...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-apollomics-aplm-and-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-apollomics-aplm-and-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APLM","CALC","BK4139","BK4007","ITRM","BK4137","HCSG"],"gpt_icon":0},{"id":"2423048375","title":"Q4 2023 Iterum Therapeutics PLC Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2423048375","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2423048375?lang=en_us&edition=fundamental","pubTime":"2024-03-29 12:09","pubTimestamp":1711685368,"startTime":"0","endTime":"0","summary":"Louise Barrett; SVP, Legal Affairs; Iterum Therapeutics plc. Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call.  I will now turn the call over to our host, Louise Barrett, Senior Vice President of Legal Affairs. Louise, please go ahead.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2023-iterum-therapeutics-plc-040928977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITRM","LENZ"],"gpt_icon":0},{"id":"2422169412","title":"BRIEF-Iterum Therapeutics Reports Q4 And Full Year 2023 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2422169412","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422169412?lang=en_us&edition=fundamental","pubTime":"2024-03-28 19:12","pubTimestamp":1711624363,"startTime":"0","endTime":"0","summary":"March 28  - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS   * RESUBMISSION OF NDA ON TRACK FOR EARLY Q2 24   * CASH RUNWAY INTO 2025Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ITRM","LENZ"],"gpt_icon":0},{"id":"2422166669","title":"Iterum Therapeutics Q4 2023 GAAP EPS $(0.94), Inline, Cash Position $23.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2422166669","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422166669?lang=en_us&edition=fundamental","pubTime":"2024-03-28 19:01","pubTimestamp":1711623674,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.94) per share which met the analyst consensus estimate.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37978188/iterum-therapeutics-q4-2023-gaap-eps-0-94-inline-cash-position-23-9m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ITRM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iterumtx.com","stockEarnings":[{"period":"1week","weight":-0.0766},{"period":"1month","weight":-0.1124},{"period":"3month","weight":-0.2565},{"period":"6month","weight":-0.4188},{"period":"1year","weight":0.0409},{"period":"ytd","weight":-0.4188}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.079617},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01483},{"month":3,"riseRate":0.5,"avgChangeRate":0.065808},{"month":4,"riseRate":0.5,"avgChangeRate":0.010815},{"month":5,"riseRate":0.333333,"avgChangeRate":0.004014},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.075471},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.146103},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.120394},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.119161},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.224211},{"month":11,"riseRate":0.5,"avgChangeRate":0.337168},{"month":12,"riseRate":0.5,"avgChangeRate":0.087662}],"exchange":"NASDAQ","name":"Iterum Therapeutics Plc","nameEN":"Iterum Therapeutics Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iterum Therapeutics Plc(ITRM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Iterum Therapeutics Plc(ITRM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Iterum Therapeutics Plc,ITRM,Iterum Therapeutics Plc股票,Iterum Therapeutics Plc股票老虎,Iterum Therapeutics Plc股票老虎国际,Iterum Therapeutics Plc行情,Iterum Therapeutics Plc股票行情,Iterum Therapeutics Plc股价,Iterum Therapeutics Plc股市,Iterum Therapeutics Plc股票价格,Iterum Therapeutics Plc股票交易,Iterum Therapeutics Plc股票购买,Iterum Therapeutics Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iterum Therapeutics Plc(ITRM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Iterum Therapeutics Plc(ITRM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction